Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial biopharma-reporter.com Submitted by Sorin61 t3_z563cl on November 26, 2022 at 12:10 PM in technology 186 comments 13,682
A_Shadow t1_ixwtyqu wrote on November 27, 2022 at 12:19 AM Reply to comment by VollgasJen in Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial by Sorin61 Nah, likely different. You would need a different vaccine for each type of cancer. Permalink Parent 5
Viewing a single comment thread. View all comments